Fullerenes used to make better, more stable MRI imaging agent. Investigators from the National Cancer Institute’s Cancer Nanotechnology Platform Partnership at Virginia Commonwealth University have developed a new imaging agent that is 40 times more potent at boosting magnetic resonance imaging (MRI) signals than agents currently approved for human clinical use.
0 comments:
Post a Comment